Cargando…
Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
Cholangiocarcinoma (CCA) is a rare primary liver cancer associated with high mortality and few systemic treatment options. The behaviour of the immune system has come into focus as a potential treatment modality for many cancer types, but immunotherapy has yet to dramatically alter the treatment par...
Autores principales: | Lu, Xinjun, Green, Benjamin L., Xie, Changqing, Liu, Chao, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205436/ https://www.ncbi.nlm.nih.gov/pubmed/37229173 http://dx.doi.org/10.1016/j.jhepr.2023.100723 |
Ejemplares similares
-
Cholangiocarcinoma in the Era of Immunotherapy
por: Manthopoulou, Eleni, et al.
Publicado: (2023) -
Latest evidence on immunotherapy for cholangiocarcinoma
por: Guo, Xurui, et al.
Publicado: (2020) -
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics
por: Golino, Jihye L., et al.
Publicado: (2023) -
The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021) -
Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)